About MHAT Yuliya Vrevska Byala
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Allergan
3
Clinical Trials at MHAT Yuliya Vrevska Byala
During the past decade, MHAT Yuliya Vrevska Byala conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis 01
2017-09-29
2020-07-08
Terminated
336
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04
2018-02-01
2020-11-05
Terminated
450
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 03
2018-01-24
2020-10-30
Terminated
467
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at MHAT Yuliya Vrevska Byala
According to Clinical.Site data, the most researched conditions in "MHAT Yuliya Vrevska Byala" are
"Diabetes Mellitus" (3 trials) and "Gastroparesis" (3 trials). Many other conditions were trialed in "MHAT Yuliya Vrevska Byala" in a lesser frequency.
Clinical Trials Intervention Types at MHAT Yuliya Vrevska Byala
Most popular intervention types in "MHAT Yuliya Vrevska Byala" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials) and "Relamorelin" (3 trials). Other intervention names were less common.
Clinical Trials Genders at MHAT Yuliya Vrevska Byala
The vast majority of trials in "MHAT Yuliya Vrevska Byala" are
3 trials for "All" genders.
Clinical Trials Status at MHAT Yuliya Vrevska Byala
Currently, there are NaN active trials in "MHAT Yuliya Vrevska Byala".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in MHAT Yuliya Vrevska Byala,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in MHAT Yuliya Vrevska Byala, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".